IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q3 2023 Holdings

Filed 2023-11-14 | 9 holdings | $26.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Savara Inc(SVRA)COM805111101$12.5M3,313,60247.6%
Xeris Biopharma Holdings Inc(XERS)COM98422E103$10.5M5,641,92039.9%
Rezolute Inc(RZLT)COM NEW76200L309$1.7M1,318,9676.6%
Molecular Templates IncCOM NEW608550208$865.0K136,8663.3%
Apogee Therapeutics Inc(APGE)COM03770N101$265.7K12,4721.0%
Compass Therapeutics Inc(CMPX)COM20454B104$170.9K86,7730.6%
Aclaris Therapeutics Inc(ACRS)COM00461U105$133.4K19,4730.5%
Allakos Inc(ALLKGUSD)COM01671P100$112.0K49,3290.4%
Elevation Oncology IncCOM28623U101$14.5K21,8130.1%